Founder and Partner at H Ventures
Check size: H Ventures does not publish a firm or person-specific check-size range on its current website.
Jongwoo focuses on biohealthcare businesses whose scientific value can be protected through strong global IP strategy. His diligence lens spans drug platforms, cell and gene therapies, medical AI, licensing and defensible patent portfolios.
Present the technical breakthrough, independent validation, IP position, commercialization milestones, team execution record and a credible path from the current stage to category leadership and exit.
H Ventures states that it seeks category-leading teams with durable technical advantages, defensible intellectual property, disciplined execution and the resilience to build through a long company journey.
No personal pass list is public. The firm explicitly avoids chasing short-term trends and appears less aligned with weak technical diligence, shallow IP moats or teams unable to execute toward category leadership.